Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
13 Cards in this Set
- Front
- Back
What are the three determinants of MVO2
|
-heart rate
-wall stress (preload & afterload) -contractility |
|
What are the determinants of O2 supply
|
-coronary blood flow
-oxygen extraction |
|
What are the categories of anti-anginal agents
|
nitrovasodilators
b-adrenergic blockers calcium channel blockers other (aspirin, heparin) |
|
What are the two main MOA of nitrovasodilators
|
-reduce O2 demand
-increase O2 supply --relax large arteries, relax veins, inhibit platelet aggregation |
|
nitroglycerin is a
-metabolism -duration |
-nitrovasodilator
-first pass hepatic metabolism -dependent on formulation |
|
isosorbide dinitrate (ISDN)
-duraction -administration |
-nitrovasodilator
-3-5 hours -3-4x daily |
|
Isosorbide mononitrate (ISMN)
-duration -metabolism |
-nitrovasodilator
-longer duration of action -minimal first pass metabolism |
|
Sildenafil, tadalafil, vardenafil
-do what -affect BP how |
-phosphodiesterase 5 inhibitors
-increase levels of cGMP -modest drop in BP, combo w/nitrates can cause hypotension though |
|
verapamil
|
-calcium channel blocker
|
|
diltiazem
|
calcium channel blocker
|
|
nifedipine, amodipine, felodipine, nicardipine, nimodipine
|
-dihydropyridines (calcium channel blockers)
|
|
ranolazine
-MOA |
-antianginal drug
-unclear, inhibitor of late sodium current resulting in a reduction of the intracellular sodium and calcium overload in ischemic myocytes |
|
clopidogrel
-MOA |
-thienopyridine
-prevents platelet aggregation by irreversibly binding ADP antagonist at P2 receptors |